NEW YORK (Reuters Health) – Discontinuation of proton pump inhibitor (PPI) therapy after esophagitis has healed does not worsen heartburn symptoms or cause persistent hypergastrinemia, according to a…
NEW YORK (Reuters Health) – Smoking, COPD and peptic ulcer disease are important risk factors for complications in patients undergoing elective primary total hip replacement (THR) or primary…
NEW YORK (Reuters Health) – Geographically, higher rates of surgery for early stage nonsmall cell lung cancer (NSCLC) are associated with improved survival, even in older and sicker…
NEW YORK (Reuters Health) – In patients newly diagnosed inoperable pancreatic cancer, it’s worth considering celiac plexus neurolysis (CPN) for pain control at the same time that endoscopic…
NEW YORK (Reuters Health) – Measuring homocysteine improves the accuracy of estimated risk of cardiovascular events, according to an analysis of data from two different sources. “Our observations…
NEW YORK (Reuters Health) – Postmenopausal women with ovarian cysts detected on ultrasound are not at increased risk of developing ovarian cancer or, for that matter, breast or…
NEW YORK (Reuters Health) – The response of adolescents with migraine to treatment with combination sumatriptan and naproxen sodium is similar to that seen in adults, with no…
Jonathan Piccini, MD, MHS discusses evaluating superiority vs non-inferiority in clinical trials, as reported in Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, M.D.,…
NEW YORK (Reuters Health) – Intensive treatment of type 2 diabetes that’s detected early through screening does not seem to reduce rates of subsequent complications, a Danish study…
NEW YORK (Reuters Health) – Five-year survival rates are not significantly different for patients with esophagogastric cancer whether they undergo transthoracic or transhiatal esophagectomy, according to the findings…
NEW YORK (Reuters Health) – For patients with inadequately controlled asthma, the combination of mometasone furoate and formoterol reduces exacerbations and slows the decline in lung function more…
NEW YORK (Reuters Health) – The beta-blocker propranolol is superior to traditional first-line oral corticosteroids in the treatment of infantile hemangiomas (IHs), conclude pediatric dermatologists from Miami, Florida.…
